263 results on '"Liu, Guang-yu"'
Search Results
2. Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
3. Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
4. Pipeline positioning by the surface-to-borehole electromagnetic induction method in a clayey deposit
5. Contralateral axillary lymph node metastasis in breast cancer: An oligometastatic-like disease
6. All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
7. Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy
8. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
9. DEM contact model for spherical and polyhedral particles based on energy conservation
10. A GPU-based DEM framework for simulation of polyhedral particulate system
11. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
12. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
13. Towards a better understanding of antimicrobial resistance dissemination: what can be learnt from studying model conjugative plasmids?
14. A novel parameter inversion method for an improved DEM simulation of a river damming process by a large-scale landslide
15. A contact detection algorithm for triangle boundary in GPU-based DEM and its application in a large-scale landslide
16. Simulation of rock fracture process based on GPU-accelerated discrete element method
17. Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
18. Clinical observation on the effect of Chinese medicine-“TCM formula” intervention on recurrence and metastasis of triple negative breast cancer
19. Study on the particle breakage of ballast based on a GPU accelerated discrete element method
20. A cohesive fracture model for discrete element method based on polyhedral blocks
21. Antimicrobial resistance crisis: could artificial intelligence be the solution?
22. Neoadjuvant Anthracycline Followed by Toripalimab Combined with Nab-Paclitaxel in Patients with Early Triple-Negative Breast Cancer (NeoTENNIS): A Single-Arm, Phase II Study
23. Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial
24. Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
25. Study on the mechanical behavior of sands using 3D discrete element method with realistic particle models
26. Hierarchical sliding-mode control of spatial inverted pendulum with heterogeneous comprehensive learning particle swarm optimization
27. Saturated control design of a quadrotor with heterogeneous comprehensive learning particle swarm optimization
28. Crystal structure determination of Scylla paramamosain arginine kinase, an allergen that may cause cross-reactivity among invertebrates
29. Handover of anesthesia care is associated with an increased risk of delirium in elderly after major noncardiac surgery: results of a secondary analysis
30. Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
31. Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: prospective clinical study
32. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study
33. Supplementary Figure from Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
34. Abstract OT3-27-01: Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: a multicenter, phase 2, umbrella, FUTURE trial
35. Neoadjuvant Pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA) and chemotherapy versus placebo plus chemotherapy in patients with HER2-negative breast cancer: a randomized, controlled, double-blind trial
36. A Novel Failure-Distribution-Dependent Non-Fragile <inline-formula><tex-math notation="LaTeX">$H_\infty$</tex-math></inline-formula> Fault-Tolerant Load Frequency Control for Faulty Multi-Area Power Systems
37. A novel failure-distribution-dependent non-fragile $H_\infty$ fault-tolerant load frequency control for faulty multi-area power systems
38. All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
39. Contact Overlap Calculation Algorithms and Benchmarks Based on Blocky Discrete-Element Method
40. Prognostic factors and clinical outcomes of breast cancer patients with disease progression during neoadjuvant systemic therapy
41. Effect of Ruai-Sanyin formula maintenance therapy after completion of standard adjuvant treatment on survival in women with early-stage triple negative breast cancer: A multicenter prospective cohort study
42. Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1–2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram
43. Accuracy of ultrasound-guided targeted fine-needle aspiration in assessing nodal response in node-positive breast cancer after neoadjuvant chemotherapy: prospective feasibility study
44. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway
45. HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression
46. Synthesis and Structure Elucidation of Two Essential Metal Complexes: In-Vitro Studies of Their BSA/HSA-Binding Properties, Docking Simulations, and Anticancer Activities
47. Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
48. Prior Local or Systemic Treatment: A Predictive Model Could Guide Clinical Decision-Making for Locoregional Recurrent Breast Cancer
49. Prognostic Factors and Clinical Outcomes of Breast Cancer Patients with Disease Progression During Neoadjuvant Systemic Therapy
50. Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.